CA2381979A1 - Polypeptides pgpcr-3 et leurs sequences d'adn - Google Patents
Polypeptides pgpcr-3 et leurs sequences d'adn Download PDFInfo
- Publication number
- CA2381979A1 CA2381979A1 CA002381979A CA2381979A CA2381979A1 CA 2381979 A1 CA2381979 A1 CA 2381979A1 CA 002381979 A CA002381979 A CA 002381979A CA 2381979 A CA2381979 A CA 2381979A CA 2381979 A1 CA2381979 A1 CA 2381979A1
- Authority
- CA
- Canada
- Prior art keywords
- polypeptide
- sequence
- polynucleotide
- seq
- isolated
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
- C07K14/723—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH receptor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Pulmonology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Physical Education & Sports Medicine (AREA)
- Psychiatry (AREA)
- Rheumatology (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Virology (AREA)
- Pain & Pain Management (AREA)
- Obesity (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Endocrinology (AREA)
- AIDS & HIV (AREA)
- Biochemistry (AREA)
- Emergency Medicine (AREA)
- Hospice & Palliative Care (AREA)
Abstract
L'invention concerne des polypeptides et des polynucléotides PGPCR-3, ainsi que des méthodes permettant de produire lesdits polypeptides par des techniques de recombinaison. L'invention concerne également des méthodes d'utilisation de ces polypeptides et polynucléotides PGPCR-3 dans le cadre d'analyses diagnostiques.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP99116093.8 | 1999-08-17 | ||
EP99116093 | 1999-08-17 | ||
PCT/EP2000/007454 WO2001012673A1 (fr) | 1999-08-17 | 2000-08-02 | Polypeptides pgpcr-3 et leurs sequences d'adn |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2381979A1 true CA2381979A1 (fr) | 2001-02-22 |
Family
ID=8238791
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002381979A Abandoned CA2381979A1 (fr) | 1999-08-17 | 2000-08-02 | Polypeptides pgpcr-3 et leurs sequences d'adn |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1203023A1 (fr) |
JP (1) | JP2003510027A (fr) |
CA (1) | CA2381979A1 (fr) |
WO (1) | WO2001012673A1 (fr) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6555339B1 (en) | 1997-04-14 | 2003-04-29 | Arena Pharmaceuticals, Inc. | Non-endogenous, constitutively activated human protein-coupled receptors |
US7119190B2 (en) | 1997-04-14 | 2006-10-10 | Arena Pharmaceuticals, Inc. | Endogenous and non-endogenous versions of human G protein-coupled receptors |
EP1171467A4 (fr) * | 1999-04-27 | 2002-07-31 | Smithkline Beecham Corp | Axor-27, recepteur couple a une proteine g |
EP1242448A2 (fr) * | 1999-11-17 | 2002-09-25 | Arena Pharmaceuticals, Inc. | Versions endogenes et non-endogenes de recepteurs couples a la proteine g humaine |
US20030152973A1 (en) * | 2000-05-24 | 2003-08-14 | Grassie Morag A | G-protein coupled receptor org3 |
WO2002101005A2 (fr) * | 2001-06-07 | 2002-12-19 | Wyeth | Recepteur couple a une proteine g et utilisations |
WO2003004530A1 (fr) * | 2001-07-06 | 2003-01-16 | Bayer Aktiengesellschaft | Régulation de la protéine semblable à un récepteur de la somatostatine humaine |
US6902902B2 (en) | 2001-11-27 | 2005-06-07 | Arena Pharmaceuticals, Inc. | Human G protein-coupled receptors and modulators thereof for the treatment of metabolic-related disorders |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE9602822D0 (sv) * | 1996-07-19 | 1996-07-19 | Astra Pharma Inc | New receptor |
US5945307A (en) * | 1998-01-26 | 1999-08-31 | Millennium Pharmaceuticals, Inc. | Isolated nucleic acid molecules encoding a G-protein coupled receptor showing homology to the 5HT family of receptors |
-
2000
- 2000-08-02 CA CA002381979A patent/CA2381979A1/fr not_active Abandoned
- 2000-08-02 WO PCT/EP2000/007454 patent/WO2001012673A1/fr not_active Application Discontinuation
- 2000-08-02 JP JP2001517571A patent/JP2003510027A/ja active Pending
- 2000-08-02 EP EP00962285A patent/EP1203023A1/fr not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
WO2001012673A1 (fr) | 2001-02-22 |
EP1203023A1 (fr) | 2002-05-08 |
JP2003510027A (ja) | 2003-03-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20010016337A1 (en) | Molecular cloning of a galanin like 7TM receptor (AXOR40) | |
US20070207506A1 (en) | G-protein coupled receptor and DNA sequences thereof | |
CA2381979A1 (fr) | Polypeptides pgpcr-3 et leurs sequences d'adn | |
CA2388308A1 (fr) | Nouveaux polypeptides de type gpcr-kd5 et sequences d'adn correspondantes | |
WO2001053308A1 (fr) | Clonage d'un recepteur 7tm d'un singe (axor8) | |
WO2001042486A1 (fr) | Axor12 | |
US20040071695A1 (en) | Novel g-protein coupled receptor | |
CA2389672A1 (fr) | Polypeptides du type gp27 et leurs sequences d'adn | |
AU2001283930B2 (en) | Novel g-protein coupled receptor | |
AU2001281836B2 (en) | A g-protein coupled receptor | |
US20050054034A1 (en) | Thyrotropin-releasing hormone receptor-like gpcr(gprfwki) | |
WO2001064836A2 (fr) | Clonage d'un variant de gpr38 | |
WO2001053337A1 (fr) | Recepteur humain axor33 7 fois transmembranaire | |
GB2365012A (en) | G protein coupled receptor AXOR89 | |
US20060154244A1 (en) | Novel g-protein coupled receptor | |
US20040106149A1 (en) | Novel gpcr hfrbn63 | |
CA2392639A1 (fr) | Recepteur htogh35 couple a la proteine g | |
GB2368065A (en) | AXOR52, a NPY-like G protein coupled receptor | |
WO2001068665A1 (fr) | Variant-1 du gene h3 de l'histamine humaine | |
WO2001061003A1 (fr) | Homologue humain du flamingo | |
WO2001025280A1 (fr) | Paul, recepteur couple a une proteine g | |
CA2391504A1 (fr) | Nouveaux polypeptides recepteurs olfactifs et sequences d'adn de ces polypeptides | |
AU2001283930A1 (en) | Novel g-protein coupled receptor | |
AU2001281836A1 (en) | A g-protein coupled receptor | |
WO2001064746A1 (fr) | Clonage moleculaire du recepteur (axor70) a sept domaines transmembranaires |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
FZDE | Dead |